medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2011, Number 95

<< Back Next >>

Rev Enfer Infec Pediatr 2011; 24.25 (95)

Kawasaki disease. Prevalence in Children’s Private Hospital

Soto AK, Saltigeral SP, Gaytán FG, Valenzuela FA

Language: Spanish
References: 28
Page: 109-113
PDF size: 187.08 Kb.


ABSTRACT

Objective: To determine the prevalence of Kawasaki Disease in children hospitalized between 1992 to 2005 at Hospital Infantil Privado.
Methods: We reviewed the pediatric patient clinical files diagnosed with Kawasaki Disease in the period of June 1992 to June 2005. The diagnosis was established with the following criteria: fever ›5 days in addition to four of the following (conjunctival hyperemia, changes in oral mucosa, changes in hands and feet, rash, cervical or submandibular lymphadenopathy.
Results: A total of 48 cases of Kawasaki Disease were identified: 58% were male, 42% female. The average age was two years. 75% of the cases occurred in winter and spring. In the last three years occurred 64.4% of the cases. The incidence of EF was 2.5 cases per 1000 hospital discharges.
Conclusions: The frequency of Kawasaki Disease has increased in recent years, mainly in children under 5 years (94%) with predominance of males, 6.3% of patients had cardiovascular complications, 6.3% of patients had recurrence.


REFERENCES

  1. Kawasaki T. Febricula oculo-oro cutaneous acrodesquamatous, syndrome with or without acute non-suppurative cervical lymphadenitis in infancy and childhood: clinical observations of 50 cases. Allergy 1967;16:178-222.

  2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-2771.

  3. Fimbres AM, Shulman ST. Kawasaki Disease. Pediatr Rev 2008;29:308-316.

  4. Holman RC, Curns AT, Belay ED, et al. Kawasaki Syndrome in Hawaii. Pediatr Infect Dis J 2005;24(5):429–433.

  5. Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease. Pediatrics 2010;125:234-41.

  6. Rodríguez-Suárez R. Síndrome linfomucutáneo. Presentación de un caso. Bol Med Hosp Infant Mex 1977;34:53-57.

  7. Vizcaíno-Alarcón A, Arévalo-Salas A, Rodríguez-López AM, Sadowinsky-PS. Enfermedad de Kawasaki en niños mexicanos. Bol Med Hosp Infant Mex 1991;48:398-408.

  8. González-Galnares M, Urban-Vázquez H, Santamaría-Díaz H y cols. Enfermedad de Kawasaki en México: análisis de 13 casos. Bol Med Hosp Infant Mex 1991;48:409-416.

  9. RODRÍGUEZ-HERRERA R, CARVAJAL-RODRÍGUEZ L, REYNÉS-MANZUR J, GARCÍA-PIÑA C, BARRIOS-FUENTES R, Y COLS: Enfermedad de Kawasaki. Acta Pediatr Mex 2001; 22(2): 97-103.

  10. Yamazaki-Nakashimada, Espinosa-López M, Contreras-Verduzco A, et al. Espectro clínico de la enfermedad de Kawasaki. Alergia, asma e inmunología pediátricas 2005;14(2):60-63.

  11. Frenkel-Salomon M, Ocaña-García LA, Bautista-Santos A, et al. Enfermedad de Kawasaki. Experiencia en ocho casos del Centro Médico ABC. An Med Asoc Med Hosp ABC 2004;49(2):66-72.

  12. De León-González M, Gaytan-Morales F, García Valdez MC. Enfermedad de Kawasaki: Reporte y seguimiento en el Hospital Juárez de México. Boletin AMUP. 2007;48:6-25.

  13. Sotelo N, Gonzalez LA. Kawasaki disease: A rare pediatric pathology in Mexico Twenty cases report from the Hospital Infantil del Estado de Sonora. Arch Cardiol Mex 2007;77(4):299-307.

  14. Quezada-Chavarría G, Ramírez-Serrallonga R, Quezada-Chavarría S, et al. Enfermedad de Kawasaki. Análisis de 17 casos. Rev Med Inst Mex Seguro Soc 2009;47(1):61-64.

  15. Del Angel-Aguilar A, Rodríguez-Herrera R, Díaz-Luna JL, et al. Enfermedad de Kawasaki Experiencia en un hospital de segundo nivel. Revista de enfermedades Infecciosas en Pediatría 2009; 22 (87): 70-76.

  16. Freeman AF, Shulman ST. Kawasaki Disease: Summary of the American Heart Association Guidelines. Am Fam Physician 2006;74:1141-8, 1149-50.

  17. Park YW, Han JW, Park IS, et al. Kawasaki disease in Korea, 2003–2005. Pediatr Infect Dis J 2007;26(9):821–823.

  18. Huang WC, Huang LM, Chang IS, et al. Epidemiologic Features of Kawasaki Disease in Taiwan, 2003-2006. Pediatrics 2009;123:401-405 .

  19. Du ZD, Zhao D, Du J, et al. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J 2007;26(5):449–451.

  20. Ng YM, Sung RY, So LY, et al. Kawasaki disease in Hong Kong, 1994 to 2000. Hong Kong Med J 2005;11(5):331-5.

  21. Huang GY, Ma XJ, Huang M, et al. Epidemiologic Pictures of Kawasaki disease in Shanghai from 1998 through 2002. J Epidemiol 2006;16:9-14.

  22. Schiller B, Fasth A, Bjorkehem G, et al. Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr 1995;84:769-74.

  23. Dhillon R, Newton L, Rudd PT, Hall SM. Management of Kawasaki disease in the British Isles. Arch Dis Child 1993;69:631-8.

  24. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-95. Arch Dis Child 1998;78:33-9.

  25. Holman RC, Curns AT, Belay ED, et al. Kawasaki Syndrome Hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112:495–501.

  26. Rodríguez-Herrera R, Carvajal-Rodríguez L, Reynés-Manzur JN, et al. Abordaje diagnóstico y terapéutico de la enfermedad de Kawasaki. Acta-Pediatr Mex 2006;27(1):36-49

  27. Del Castillo MF. Enfermedad de Kawasaki. Semin Fund Esp Reumatol 2006; 7:70-83

  28. Coria J, Cervantes V, Urtiz F, et al. Características clínicas de niños con Kawasaki atípico en un hospital de alta especialización. Rev Mex Pediatr 2007; 74(1); 9-15




2020     |     www.medigraphic.com